Semi-Annual Statement Of Income And Retained Earnings

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7310818

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-195,000,000 JPY
884,000,000 JPY
1,086,000,000 JPY
482,000,000 JPY
-401,000,000 JPY
-6,000,000 JPY
-11,000,000 JPY
514,000,000 JPY
-396,000,000 JPY
-407,000,000 JPY
-492,000,000 JPY
95,000,000 JPY
Non-operating income
Non-operating income
63,000,000 JPY
51,000,000 JPY
Non-operating expenses
Non-operating expenses
18,000,000 JPY
165,000,000 JPY
Ordinary profit (loss)
528,000,000 JPY
-510,000,000 JPY
Extraordinary income
Extraordinary income
200,000,000 JPY
87,000,000 JPY
Extraordinary losses
Extraordinary losses
4,000,000 JPY
69,000,000 JPY
Profit (loss) before income taxes
724,000,000 JPY
-492,000,000 JPY
Income taxes - current
27,000,000 JPY
7,000,000 JPY
Income taxes - deferred
-68,000,000 JPY
14,000,000 JPY
Profit (loss)
764,000,000 JPY
-514,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.